Loading company…
Sensorion develops therapies for hearing loss and other inner ear diseases.
Sensorion is a biopharmaceutical company developing therapies for inner ear diseases, including hearing loss, vertigo, and balance disorders. Founded in 2009, the company is based in Montpellier, France. In February 2024, it raised EUR 60 million in PIPE funding from Sanof, Cormorant Asset Management, Coastlands Capital, Sphera Fund Management, Artal Capital, Redmile Group, and Sofinnova Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in